| Literature DB >> 31098004 |
Philip Garner1, Philip B Cox2, Upendra Rathnayake1, Nicholas Holloran1, Paul Erdman2.
Abstract
Fragment-based drug discovery (FBDD) is a well-established technology for lead compound generation in drug discovery. As this technology has evolved, the design of fragments for screening has also evolved to engender not just an understanding of the role of modulating the physicochemical properties of fragments (Rule of Three, Ro3) but also the importance and implications of incorporating shape and, in particular, 3D characteristics into fragments. Herein, we describe the design and synthesis of pyrrolidine-based fragments with good fragment-like (Ro3) physicochemical properties that effectively sample three-dimensional molecular space.Entities:
Year: 2019 PMID: 31098004 PMCID: PMC6511948 DOI: 10.1021/acsmedchemlett.9b00070
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345